Publication: Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer
1
Issued Date
2013-07-01
Resource Type
ISSN
16159861
16159853
16159853
Other identifier(s)
2-s2.0-84880627384
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Proteomics. Vol.13, No.14 (2013), 2088-2099
Suggested Citation
Voraratt Champattanachai, Pukkavadee Netsirisawan, Parunya Chaiyawat, Thanong Phueaouan, Ratana Charoenwattanasatien, Daranee Chokchaichamnankit, Phaibul Punyarit, Chantragan Srisomsap, Jisnuson Svasti Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer. Proteomics. Vol.13, No.14 (2013), 2088-2099. doi:10.1002/pmic.201200126 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/31285
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer
Abstract
O-GlcNAcylation is a dynamic PTM of nuclear and cytoplasmic proteins, regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase, which catalyze the addition and removal of O-GlcNAc, respectively. This modification is associated with glucose metabolism, which plays important roles in many diseases including cancer. Although emerging evidence reveals that some tumor-associated proteins are O-GlcNAc modified, the total O-GlcNAcylation in cancer is still largely unexplored. Here, we demonstrate that O-GlcNAcylation was increased in primary breast malignant tumors, not in benign tumors and that this augmentation was associated with increased expression of OGT level. Using 2D O-GlcNAc immnoblotting and LC-MS/MS analysis, we successfully identified 29 proteins, with seven being uniquely O-GlcNAcylated or associated with O-GlcNAcylation in cancer. Of these identified proteins, some were related to the Warburg effect, including metabolic enzymes, proteins involved in stress responses and biosynthesis. In addition, proteins associated with RNA metabolism, gene expression, and cytoskeleton were highly O-GlcNAcylated or associated with O-GlcNAcylation. Moreover, OGT knockdown showed that decreasing O-GlcNAcylation was related to inhibition of the anchorage-independent growth in vitro. These data indicate that aberrant protein O-GlcNAcylation is associated with breast cancer. Abnormal modification of these O-GlcNAc-modified proteins might be one of the vital malignant characteristics of cancer. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.